Frontiers in Interventional Cardiology
Data up to Jan 2025
Total Citations Per Year
Abstract
References (146)
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 • 4,561 citations
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
1994 • 4,260 citations
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 • 2,614 citations
A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents
1996 • 2,032 citations
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 • 1,922 citations
Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty
1987 • 1,870 citations
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 • 1,395 citations
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
1997 • 1,346 citations
A completely biological tissue-engineered human blood vessel
1998 • 1,324 citations
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction
1998 • 1,263 citations
Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
1992 • 1,166 citations
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
1996 • 980 citations
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
1987 • 964 citations
Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty
1997 • 950 citations
Matrix Metalloproteinases and Cardiovascular Disease
1995 • 873 citations
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
1994 • 852 citations
Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
1997 • 821 citations
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.
1995 • 783 citations
Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine
1995 • 769 citations
A Novel Method for Nonfluoroscopic Catheter-Based Electroanatomical Mapping of the Heart
1997 • 755 citations
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
1992 • 749 citations
Angiographic Follow-up after Placement of a Self-Expanding Coronary-Artery Stent
1991 • 737 citations
Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction
1998 • 723 citations
A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease
1993 • 703 citations
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.
1995 • 688 citations
THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
1988 • 669 citations
Relationship Between Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute Myocardial Infarction
1999 • 574 citations
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy
1993 • 549 citations
Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4
1996 • 547 citations
Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis
1995 • 545 citations
Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors
1998 • 541 citations
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
1993 • 459 citations
Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene Product
1995 • 455 citations
Initial events in interactions of blood with a foreign surface
1969 • 449 citations
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
1994 • 443 citations
A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal Residue
1983 • 437 citations
Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases
1998 • 428 citations
Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries
1996 • 404 citations
Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention
1997 • 399 citations
International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable Angina
1998 • 391 citations
Gene therapy inhibiting neointimal vascular lesion
1995 • 387 citations
Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions
1996 • 383 citations
Nonfluoroscopic, in vivo navigation and mapping technology
1996 • 380 citations
Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes
1993 • 371 citations
Immediate vs Delayed Catheterization and Angioplasty Following Thrombolytic Therapy for Acute Myocardial Infarction
1988 • 358 citations
Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction
1998 • 336 citations
Seeding of intravascular stents with genetically engineered endothelial cells.
1989 • 328 citations
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
1998 • 320 citations
Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease
1997 • 317 citations
Regulation of Vascular Smooth Muscle Cell Migration and Proliferation In Vitro and in Injured Rat Arteries by a Synthetic Matrix Metalloproteinase Inhibitor
1996 • 311 citations
Inhibition of Matrix Metalloproteinase Activity Inhibits Smooth Muscle Cell Migration but Not Neointimal Thickening After Arterial Injury
1996 • 307 citations
Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial
2001 • 304 citations
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
1994 • 290 citations
A Randomized Comparison of Combined Ticlopidine and Aspirin Therapy Versus Aspirin Therapy Alone After Successful Intravascular Ultrasound–Guided Stent Implantation
1996 • 287 citations
Prognostic Implication of Creatine Kinase Elevation Following Elective Coronary Artery Interventions
1997 • 278 citations
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
1997 • 273 citations
Toward a New Frontier in Myocardial Reperfusion Therapy
1998 • 264 citations
Continued benefit of coronary stenting versus balloon angioplasty: One-year clinical follow-up of Benestent trial
1996 • 261 citations
The electrochemical behavior of metallic implant materials as an indicator of their biocompatibility
1987 • 261 citations
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
1994 • 250 citations
Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.
1994 • 245 citations
Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.
1996 • 243 citations
Human Endothelial Nitric Oxide Synthase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation After Balloon Injury in Rats
1998 • 240 citations
Transmyocardial laser revascularization: Clinical experience with twelve-month follow-up
1996 • 237 citations
Low-Dose Radioactive Endovascular Stents Prevent Smooth Muscle Cell Proliferation and Neointimal Hyperplasia in Rabbits
1995 • 223 citations
Transmyocardial laser revascularization: Operative techniques and clinical results at two years
1996 • 221 citations
Arterial Gene Therapy for Therapeutic Angiogenesis in Patients With Peripheral Artery Disease
1995 • 216 citations
Subacute stent thrombosis: Evolving issues and current concepts
1996 • 211 citations
Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein
1998 • 196 citations
Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation
1992 • 190 citations
Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries
1996 • 188 citations
Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome
1993 • 180 citations
Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency.
1994 • 171 citations
Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.
1992 • 171 citations
Outpatient Coronary Stent Implantation
1997 • 171 citations
Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries
1994 • 160 citations
Local adenoviral–mediated expression of recombinant hirudin reduces neointima formation after arterial injury
1996 • 159 citations
Inhibition of Neointimal Proliferation With Low-Dose Irradiation From a β-Particle–Emitting Stent
1996 • 158 citations
Restoration of Coronary Flow in Myocardial Infarction by Intravenous Chimeric 7E3 Antibody Without Exogenous Plasminogen Activators
1997 • 152 citations
The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures
1996 • 140 citations
Pure β-ParticleEmitting Stents Inhibit Neointima Formation in Rabbits
1996 • 132 citations
Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent.
1991 • 129 citations
Effects of Endovascular Radiation From a β-Particle–Emitting Stent in a Porcine Coronary Restenosis Model
1996 • 128 citations
Low-dose, beta-particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation.
1994 • 126 citations
Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.
1994 • 120 citations
Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid Artery
1994 • 116 citations
Paired Comparison of Vascular Wall Reactions to Palmaz Stents, Strecker Tantalum Stents, and Wallstents in Canine Iliac and Femoral Arteries
1996 • 112 citations
Polymeric stenting in the porcine coronary artery model: Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents
1994 • 109 citations
c- myc in Vasculoproliferative Disease
1995 • 108 citations
A Call for Provisional Stenting
1998 • 102 citations
Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary palmaz-schatz stenting
1996 • 102 citations
Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro.
1992 • 97 citations
Structure-Function Relationships in the Tissue Inhibitors of Metalloproteinases
1994 • 95 citations
Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury.
1998 • 94 citations
One-month histologic response of transmyocardial laser channels with molecular intervention
1996 • 94 citations
Abciximab Therapy and Unplanned Coronary Stent Deployment
1998 • 92 citations
Clinical report: Laser myocardial revascularization
1986 • 88 citations
Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis
1996 • 86 citations
Investigation of three‐surface properties of several metals and their relation to blood compatibility
1972 • 85 citations
Coronary stenting with a new, radiopaque, balloon-expandable endoprosthesis in pigs.
1991 • 81 citations
A novel strategy for stent deployment in the treatment of acute or threatened closure complicating ballon coronary angioplasty
1993 • 79 citations
Influence of surface texture and charge on the biocompatibility of endovascular stents.
1995 • 79 citations
Antithrombotic Potential of Polymer-Coated Stents Eluting Platelet Glycoprotein IIb/IIIa Receptor Antibody
1996 • 77 citations
Endothelialization of Intravascular Stents
1988 • 75 citations
Subacute Thrombosis and Vascular Injury Resulting From Slotted-Tube Nitinol and Stainless Steel Stents in a Rabbit Carotid Artery Model
1996 • 75 citations
Subacute Stent Thrombosis and the Anticoagulation Controversy: Changes in Drug Therapy, Operator Technique, and the Impact of Intravascular Ultrasound
1996 • 73 citations
Biocompatibility of polyurethane-coated stents: Tissue and vascular aspects
1998 • 67 citations
Effects of design geometry of intravascular endoprostheses on stenosis rate in normal rabbits
1992 • 64 citations
Stent-induced Intimal Hyperplasia: Are There Fundamental Differences between Flexible and Rigid Stent Designs?
1994 • 63 citations
Seeding of intracoronary stents with immortalized human microvascular endothelial cells
1995 • 55 citations
Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial
1998 • 49 citations
The Beta-Particle—Emitting Radioisotope Stent (Isostent): Animal Studies and Planned Clinical Trials
1996 • 48 citations
Measurement of myocardial blood flow using positron emission tomography before and after transmyocardial revascularization
1998 • 44 citations
Comparison of the thrombogenicity of stainless steel and tantalum coronary stents
1995 • 44 citations
The importance of adequate anticoagulation to prevent early thrombosis after stenting of stenosed venous bypass grafts
1991 • 43 citations
Effect of local delivery of heparin and methotrexate on neointimal proliferation in stented porcine coronary arteries
1992 • 39 citations
Acute and chronic effects of self-expanding nitinol stents in porcine coronary arteries
1997 • 37 citations
The Antiatherogenic Effect of Iridium192 upon the Cholesterolfed Rabbit*
1964 • 34 citations
Biodegradable Stents: The Future of Interventional Cardiology?
1995 • 33 citations
In the blood: proposed new requirements for registering generic drugs
1998 • 32 citations
Mechanical features of the duke biodegradable intravascular stent
1991 • 32 citations
Arterial autologous graft-stent for treatment of coronary artery disease: A new technique
1997 • 26 citations
Composition of Human Thrombus Assessed by Quantitative Colorimetric Angioscopic Analysis
1997 • 20 citations
Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation.
1995 • 19 citations
Relation of thrombotic occlusion of coronary stents to the indication for stenting, stent size, and anticoagulation
1995 • 19 citations
Metallic Surface Treatment Using Electrochemical Polishing Decreases Thrombogenicity and Neointimal Hyperplasia After Coronary Stent Implantation in a Porcine Model
1998 • 18 citations
Integrelin for emergency coronary artery stenting
1996 • 16 citations
Neointima Formation in Injured Hamster Carotid Artery Is Effectively Prevented by the Combination G4120 and Quinapril
1996 • 15 citations
Metallic surface treatment using electrochemical polishing decreases thrombogenicity and neointimal hyperplasia after coronary stent implantation in a porcine model
1998 • 13 citations
Bioabsorbable, Drug-Eluting, Intracoronary Stents: Design and Future Applications
1992 • 12 citations
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention
1998 • 9 citations
In-vitro thrombus formation of stent wires: Role of metallic composition and heparin coating
1991 • 9 citations
1001-29 Prevention of Subacute Stent Thrombosis by Polymer-Polyethylene Oxide-Heparin Coating in the Rabbit Carotid Artery
1995 • 8 citations
Autologous vein graft-coated stent for the treatment of coronary artery disease: Immediate results after percutaneous implantation in humans
1996 • 6 citations
Feasibility study of percutaneous transluminal myocardial revascularization (PTMR) with a Holmium laser and fiberoptic delivery system
1998 • 5 citations
Local perivascular basic fibroblast growth factor (bFGF) treatment in patients with ischemic heart disease
1998 • 4 citations
Multicenter aspirin and ticlopidine trial after intracoronary stenting in high risk patients
1998 • 4 citations
793-4 Local Delivery of C-myb Antisense attenuates Neo-Intimal Thickening in a Porcine Model of Coronary Angioplasty
1995 • 4 citations
Stents Coated by an Autologous Arterial Graft: The First Application in Human Coronary Arteries
1998 • 3 citations
Percutaneous transluminal myocardial revacularization (PTMR): procedural results and early clinical outcome
1998 • 3 citations
967-20 Reduced Thrombogenicity of Nitinol vs Stainless Steel Slotted-Tube Stents in Rabbit Carotid Arteries
1995 • 3 citations
Primary autologous vein graft-coated stent in acute myocardial infarction : Immediate and short-term results
1996 • 2 citations
Stents coated by an autologous arterial graft: the first application in human coronary arteries
1998 • 2 citations
Transmyocardial laser revascularization increases dobutamine-induced angina threshold in patients with refractory angina
1998 • 1 citations
The impact of laser transmyocardial revascularization on indices of ventricular repolarization
1998 • 1 citations
Deleted Work
1955 • 0 citations